ADravet Syndrome Foundation, is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures. it affects 1:15,700 individuals, 80% of whom have a mutation in their SCN1A gene . “While seizures persist, other comorbidities such as developmental delay and abnormal EEGs are often not evident until the second or third year of life” according to Dravet syndrome Foundation.
A severe form of epilepsy, Lennox-Gastaut that begins in childhood. It is often accompanied with a myriad of seizures in addition to intellectual disability. The ailment typically surfaces at childhood–between ages 3 to 5 years old.
It was reported by SandHills Express.com that “Epidolex, a medication formulated from a cannabidiol (CBD) substance derived from the marijuana plan was approved by the US FDA for children and adults over the age of 2.”
Epidiolex, a medication formulated from a cannabidiol (CBD) substance derived from the marijuana plant was approved by the U.S. Food and Drug Administration (FDA) for children and adults over the age of 2.
View article here